Allergan Receives Positive Opinions for First-of-Its-Kind, Fully in vitro, Cell-Based Assay for BOTOX® and VISTABEL®

MARLOW, England--(BUSINESS WIRE)--Allergan is pleased to announce the company has received two positive opinions regarding its fully in vitro, cell-based assay for use in the stability and potency testing of BOTOX® and VISTABEL® (Allergan’s botulinum toxin type A products). Upon approval, the new assay will be implemented as quickly as possible for the release of product for sale in the relevant countries. Allergan estimates that use of the new assay will reduce the use of animal-based assay tes

Feed Date: 
February 22, 2012